Nanopublication

< Home

ID

http://purl.org/np/RAmhgfMT81pvxE-TD0vTNffPUmnheLfc5_MzUOHz582cI

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAmhgfMT81pvxE-TD0vTNffPUmnheLfc5_MzUOHz582cI> .
@prefix sub: <http://purl.org/np/RAmhgfMT81pvxE-TD0vTNffPUmnheLfc5_MzUOHz582cI#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix nkg: <https://w3id.org/neurodkg/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_14330> schema:possibleTreatment sub:medtherapy .
  
  sub:medtherapy prov:wasDerivedFrom sub:quote;
    schema:drug <http://identifiers.org/drugbank/DB00376>;
    schema:targetPopulation sub:targetpop;
    nkg:indicationType nkg:AdjunctiveTherapy .
  
  sub:quote prov:value "Trihexyphenidyl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa.";
    prov:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6f08000-e973-4bab-810c-b69f6c8ee4f3> .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "VnZk9Evrh1TBaWStExsEctrtCh0Ffds3RGVSnKXvqh0kn0HPrOtFdTfMoGLd0G4AvOJh94+jy1NYLbSjdBMJ8VBTqblf8LJb6OadpDGH6Tri4Tqh6MC929OwoSoo90axYviSxU8GCVhJ6RwBYX97oK5Aac6VOjQRU8PC4SOIgtU=";
    npx:hasSignatureTarget this: .
  
  this: dcterms:created "2021-04-03T11:43:28.407+02:00"^^xsd:dateTime;
    dcterms:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA64ptuigOfVGfIhpdwWeJnssaHV9jTQCnAm6Pvgrvmos> .
}